Nilotinib attenuates vascular pathology in experimental cerebral malaria.

Blood Adv · 2025 · PMC12143834 · PMID 39993234

Europe PMC DOI

hedged sentence

0.0572

closest p · 1.1× alpha

0.0572

boldest claim

The sentences

showed a trendP = .0572so close (0.05 < p ≤ 0.1)

The combined nilotinib + artesunate treatment reduced brain edema ( P = .01) and showed a trend toward reduced lung edema that did not achieve statistical significance ( P = .0572; Figure 6 H-I).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.